A subscription to JoVE is required to view this content. Sign in or start your free trial.

Case Report

Primary Ovarian Epithelioid Angiosarcoma with Extensive Lymph Node Metastases: A Case Report and Literature Review

64 views

DOI:

10.3791/72232

August 14th, 2026

* These authors contributed equally

In This Article

Summary

Primary ovarian epithelioid angiosarcoma is an exceptionally rare, aggressive vascular malignancy with a challenging preoperative diagnosis. This report describes extensive pelvic and para-aortic lymph node metastases and diffuse intra-abdominal dissemination, confirmed by histopathology and immunohistochemistry. Complete macroscopic cytoreduction was feasible, but prognosis remained poor, highlighting the need for improved therapies worldwide.

Abstract

Primary ovarian epithelioid angiosarcoma (EAS) is an exceptionally rare and highly aggressive vascular malignancy with only isolated cases reported in the literature. Owing to its nonspecific clinical presentation and overlapping radiological features, preoperative diagnosis is extremely challenging and often mimics more common gynecologic malignancies. Consequently, evidence regarding optimal diagnosis and management remains limited.

A 61-year-old postmenopausal woman presented with abdominal pain and a rapidly enlarging pelvic mass. Ultrasonography, computed tomography, and magnetic resonance imaging demonstrated a giant hypervascular pelvic tumor with extensive pelvic and para-aortic lymphadenopathy, initially suggesting uterine sarcoma. Serum CA125 and lactate dehydrogenase levels were elevated. Exploratory laparotomy identified a dominant right ovarian hypervascular tumor with diffuse peritoneal dissemination and bulky pelvic and para-aortic nodal metastases. Comprehensive clinical, radiological, intraoperative, gross pathological, histopathological, and immunohistochemical assessment demonstrated a primary ovarian origin, with no evidence of an extra-ovarian primary angiosarcoma. The patient underwent radical cytoreductive surgery, including total hysterectomy, bilateral salpingo-oophorectomy, omentectomy, appendectomy, resection of visible metastatic lesions, and systematic pelvic and para-aortic lymphadenectomy, achieving complete macroscopic cytoreduction. Histopathological examination demonstrated epithelioid tumor cells with vasoformative differentiation, while immunohistochemistry showed diffuse strong positivity for CD31, CD34, and FLI1, confirming primary ovarian epithelioid angiosarcoma. The patient declined adjuvant chemotherapy, developed rapid postoperative disease progression, and died approximately 2 months after surgery.

This case highlights the marked diagnostic challenges and highly aggressive biological behavior of primary ovarian EAS with extensive pelvic and para-aortic lymph node metastases and diffuse intra-abdominal dissemination. Accurate diagnosis required a comprehensive clinicopathological correlation supported by histopathological and immunohistochemical evaluation. Although complete macroscopic cytoreduction and systematic lymphadenectomy were technically feasible, their therapeutic benefit cannot be inferred from a single case. This report expands the limited literature and emphasizes the need for improved diagnostic strategies, collaborative data collection, and more effective systemic therapies for this rare malignancy.

Introduction

Epithelioid angiosarcoma (EAS) is a rare and highly aggressive malignant vascular neoplasm of mesenchymal origin with endothelial differentiation, accounting for approximately 1%–2% of all soft tissue sarcomas1. Epithelioid angiosarcoma is a distinct histological variant of angiosarcoma characterized by malignant endothelial cells with epithelioid morphology, marked cytologic atypia, and vasoformative differentiation, as recognized in the current World Health Organization (WHO) classification of soft tissue and bone tumors2. Epithelioid angiosarcoma has subsequently been reported in multiple anatomical locations, i....

Access restricted. Please log in or start a trial to view this content.

Protocol

The surgical management was performed in accordance with institutional and national ethical guidelines. The case report and surgical protocol were reviewed and approved by the Institutional Ethics Committee of Gansu Provincial Maternal and Child Health Hospital. Written informed consent for treatment and publication of the case details and accompanying images was obtained from the patient prior to their passing.

1. Preoperative clinical evaluation

  1. Initial clinical assessment
    1. The patient underwent a detailed clinical evaluation following presentation with intermittent abdominal pain and progressive ab....

Access restricted. Please log in or start a trial to view this content.

Results

Following appropriate preoperative evaluation and exploratory laparotomy, a dominant hypervascular tumor arising from the right ovary was identified intraoperatively. Extensive metastatic dissemination involving the contralateral ovary, uterine serosa, cervix, pelvic peritoneum, sigmoid mesentery, appendix, and pelvic and para-aortic lymph nodes was observed. Figure 1 illustrates the preoperative radiological findings and intraoperative surgical findings. Radical cytoreductive surgery, inclu.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Primary ovarian angiosarcoma is an exceptionally rare and highly aggressive malignant neoplasm of vascular endothelial origin. The largest clinicopathological analysis was reported by Nielsen et al.11, who described seven ovarian angiosarcoma cases and emphasized the aggressive biological behavior and poor prognosis associated with this entity. Subsequent reports11,12,13,14

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing interests.

Acknowledgements

This work was partially supported by the Natural Science Foundation of Gansu Province (Grant No. 24JRRA621) and the Natural Science Foundation of Gansu Province (Grant No. 22JR5RA718) and the General Project of Scientific Research Fund, Gansu Provincial Maternity and Child-care Hospital (Gansu Provincial Central Hospital) (Grant No.GMCCH2025-3-2)

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
10% Neutral Buffered FormalinSigma-Aldrich (Merck)HT501128Tissue fixation
Automated Tissue ProcessorLeica BiosystemsASP300 STissue processing
Autostainer Link 48Agilent (Dako)Autostainer Link 48Immunohistochemistry
BCOR antibodySanta Cruz Biotechnologysc-5145761:100 (dilution)
CD10 antibodyLeica BiosystemsPA02701:100 (dilution)
CD31 antibody (JC70A)Agilent/DakoM08231:100 (dilution)
CD34 antibody (QBEnd/10)Agilent/DakoM71651:100 (dilution)
cellSens StandardOlympuscellSensImage analysis
CK AE1/AE3Agilent/DakoM35151:200 (dilution)
CT ScannerSiemens HealthineersSOMATOMContrast CT
D2-40 antibodyAgilent/DakoM36191:100 (dilution)
DAB ChromogenAgilent (Dako)K3468Chromogen
DP74 CameraOlympusDP74Image acquisition
EMA antibody (E29)Agilent/DakoM06131:200 (dilution)
EnVision FLEX HRP Detection KitAgilent (Dako)K8002Polymer HRP detection
ERG antibody (EP111)Cell Marque280M1:100 (dilution)
FLI1 antibody (MRQ-1)Cell Marque249M1:100 (dilution)
HMB45 antibodyAgilent/DakoM06341:100 (dilution)
IBM SPSS Statistics v26IBMv26Statistical analysis
Ki-67 antibodyAgilent/DakoM72401:100 (dilution)
Mayer's HematoxylinAgilent (Dako)S3309Counterstain
Microtome RM2235Leica BiosystemsRM2235Cut 4 μm FFPE sections
MRI ScannerSiemens HealthineersMAGNETOMPreoperative MRI
Olympus BX53 MicroscopeOlympusBX53Histopathology
p53 antibodyAgilent/DakoM70011:100 (dilution)
Paraffin Embedding MediumLeica Biosystems39601095Paraffin embedding
PAX8 antibodyCell Marque363M1:100 (dilution)
Positively Charged Microscope SlidesThermo Fisher ScientificJ1800AMNZMount tissue sections
SMARCA4 (BRG1) antibodyAbcamab1106411:100 (dilution)
TFE3 antibodyCell Marque367M1:100 (dilution)
Ultrasound SystemGE HealthcareLOGIQ E9Color Doppler ultrasound
Vimentin antibodyAgilent/DakoM07251:200 (dilution)
Water BathLeica BiosystemsHI1210Section flotation
WT1 antibodyAgilent/DakoM35611:100 (dilution)

References

  1. Khalil MF, Thomas A, Aassad A, Rubin M, Taub RN. Epithelioid angiosarcoma of the small intestine after occupational exposure to radiation and polyvinyl chloride: a case report and review of the literature. Sarcoma. 2005;9(3–4):161–164.
  2. WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours. 5th ed. International Agency for Research on Cancer (IARC); Lyon; 2020.
  3. Fariña MC, et al. Epithelioid angiosarcoma of the breast involving the skin: a highly aggressive neoplasm readily mistaken for mammary carcinoma. J Cutan Pathol. 2003;30(2):152–156.
  4. Singh C, Xie L, Schmechel SC, Manivel JC, Pambuccian SE. Epithelioid a....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Cytoreductive SurgeryImmunohistochemical EvaluationHistopathological AssessmentPelvic LymphadenopathyPara Aortic LymphadenopathyVascular MalignancyCD31 MarkerOvarian Tumor